Literature DB >> 25599353

Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease?

Evan L Brittain, Anna R Hemnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25599353      PMCID： PMC5679119          DOI： 10.7326/M14-2700

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.

Authors:  Anna R Hemnes; Aaron W Trammell; Stephen L Archer; Stuart Rich; Chang Yu; Hui Nian; Niki Penner; Mitchell Funke; Lisa Wheeler; Ivan M Robbins; Eric D Austin; John H Newman; James West
Journal:  Circulation       Date:  2014-10-31       Impact factor: 29.690

2.  An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.

Authors:  Raymond L Benza; Dave P Miller; Robyn J Barst; David B Badesch; Adaani E Frost; Michael D McGoon
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

3.  Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension.

Authors:  David Langleben; Stylianos E Orfanos; Michele Giovinazzo; Robert D Schlesinger; Andrew M Hirsch; Fay Blenkhorn; Lyda Lesenko; Apostolos Armaganidis; John D Catravas
Journal:  Ann Intern Med       Date:  2015-01-20       Impact factor: 25.391

4.  Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension.

Authors:  Evan L Brittain; Meredith E Pugh; Lisa A Wheeler; Ivan M Robbins; James E Loyd; John H Newman; Eric D Austin; Anna R Hemnes
Journal:  JACC Heart Fail       Date:  2013-08       Impact factor: 12.035

5.  Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans.

Authors:  S E Orfanos; D Langleben; J Khoury; R D Schlesinger; L Dragatakis; C Roussos; J W Ryan; J D Catravas
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

6.  Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Marc Humbert; Xavier Jaïs; Vincent Ioos; Abdul M Hamid; Steeve Provencher; Gilles Garcia; Florence Parent; Philippe Hervé; Gérald Simonneau
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

7.  Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.

Authors:  H I Palevsky; B L Schloo; G G Pietra; K T Weber; J S Janicki; E Rubin; A P Fishman
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

8.  Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury.

Authors:  S E Orfanos; A Armaganidis; C Glynos; E Psevdi; P Kaltsas; P Sarafidou; J D Catravas; U G Dafni; D Langleben; C Roussos
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

9.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690
  9 in total
  2 in total

1.  Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.

Authors:  David Langleben; Stylianos Orfanos
Journal:  Pulm Circ       Date:  2017-06-20       Impact factor: 3.017

Review 2.  Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?

Authors:  Gareth R Willis; Angeles Fernandez-Gonzalez; Monica Reis; S Alex Mitsialis; Stella Kourembanas
Journal:  Int J Mol Sci       Date:  2018-08-27       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.